Milacemide

Milacemide
IUPAC name N2-Pentylglycinamide
Other names 2-(Pentylamino)acetamide
Identifiers
CAS number	76990-56-2 Y
PubChem	53569
ChemSpider	48376
UNII	0HXT24RECU
Jmol-3D images	Image 1
SMILES O=C(N)CNCCCCC
InChI InChI=1S/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10) Key: GJNNXIYZWIZFRH-UHFFFAOYSA-N InChI=1/C7H16N2O/c1-2-3-4-5-9-6-7(8)10/h9H,2-6H2,1H3,(H2,8,10) Key: GJNNXIYZWIZFRH-UHFFFAOYAI
Properties[1]
Molecular formula	C7H16N2O
Molar mass	144.21 g mol−1
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
Infobox references

Milacemide is a MAO-B inhibitor and glycine prodrug.^[2] It has been studied for its effects on human memory and as a potential treatment for the symptoms of Alzheimer's disease.^[3] Early clinical trials, however, showed no positive results.^[2]

References

1. ^ PubChem 53569
2. ^ ^{a b} Dysken, MW; Mendels, J, LeWitt, P, Reisberg, B, Pomara, N, Wood, J, Skare, S, Fakouhi, JD, Herting, RL (1992 May). "Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.". Journal of the American Geriatrics Society 40 (5): 503–6. PMID 1634705. http://www.ncbi.nlm.nih.gov/pubmed/1634705. 
3. ^ Harris, Carol Turkington ; foreword by Joseph R. (2002). The encyclopedia of the brain and brain disorders (2nd ed. ed.). New York, NY: Facts on File. ISBN 081604774X. http://www.scribd.com/doc/10098801/The-Encyclopedia-of-the-Brain-and-Brain-Disorders.